Aura Biosciences

About:

Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.

Website: http://www.aurabiosciences.com

Twitter/X: aurabiosciences

Top Investors: Alexandria Venture Investments, Arix Bioscience, Lysosomal Therapeutics, Surveyor Capital, Rock Springs Capital

Description:

Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor-targeted pseudovirions. The company is applying nanotechnology to help fight cancer in the well-studied area of chemotherapeutics and the emerging field of RNAi. By safely eliminating cancer locally, they can treat early and transform the lives of people with a wide range of cancers that are poorly managed today. The company's goal is to treat small ocular melanomas potentially long before the disease progresses and metastasizes to the liver, where it almost always is fatal. Aura Biosciences was founded in 2007 and is headquartered in Cambridge, Massachusetts.

Total Funding Amount:

$381M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2007-01-01

Contact Email:

inquiries(AT)aurabiosciences.com

Founders:

Elisabet de los Pinos

Number of Employees:

51-100

Last Funding Date:

2023-11-06

IPO Status:

Public

© 2025 bioDAO.ai